ruchika, Medical Dialogues

Top

Dermatology

facebook
twitter

Sign in Signup

This site is intended for healthcare professionals only

facebook
twitter

Sign in Signup

Medical Jobs
Medical Matrimony
MD Brand Connect
Corona Updates

Medical News
Health news
Medical Guidelines
AYUSH
State News
Medical Education
Industry

This site is intended for healthcare professionals only

Sign In Register

Sign inRegister

Home
Medical news
Health news
Medical Guidelines
Medical Education
Industry
Case of the Day
Editorial

ruchika

Ruchika joined Medical Dialogue an Desk Editor for the Business Section in 2019. She Covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She is a graduate from Delhi University. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751

Home
ruchika

Articles By : ruchika

Caplin Steriles, JAMP Pharma Group collaborate for 6 injectable products in Canada

ruchika19 Jan 2021 7:12 AM GMT

Chennai: Caplin Point Laboratories Limited has recently announced that Caplin Steriles Limited (a Subsidiary of Caplin Point Laboratories Ltd) has ent...

COVID-19: India to gift 2 million doses of Covishield to Bangladesh

ruchika19 Jan 2021 7:10 AM GMT

Dhaka: Bangladesh will receive 2 million doses of Covid-19 vaccine 'Covishield' as a gift from India on January 20.Citing the letter by the Indian High...

Neuberg Diagnostics gets ICMR nod to conduct COVID-19 tests in 4 cities

ruchika19 Jan 2021 6:38 AM GMT

Chennai: Leading diagnostics lab chain Neuberg Diagnostics on Monday said it has received approval from the Indian Council of Medical Research to condu...

Examining to aid CureVac with experimental COVID-19 vaccine: Bayer CEO

ruchika19 Jan 2021 4:30 AM GMT

Berlin: German pharmaceutical giant Bayer is examining whether it can help CureVac to produce its experimental COVID-19 vaccine, its chief executive wa...

Metropolis Healthcare to buy Hitech Diagnostic Centre

ruchika18 Jan 2021 6:45 AM GMT

By the acquisition, Metropolis will get an access to 31 laboratories, including three NABL-and ICMR-accredited laboratories and 68 collection centres...

AstraZeneca lung cancer drug Imfinzi gets nod for new dosing regimen in EU, UK

ruchika18 Jan 2021 5:00 AM GMT

New Delhi: AstraZeneca has recently announced that the company's Imfinzi (durvalumab) has been approved in the European Union and the UK for an additio...

Pfizer reassures Europe over COVID-19 vaccines as pandemic grows

ruchika18 Jan 2021 3:30 AM GMT

Paris: Pharma giant Pfizer tried to ease concerns in Europe about deliveries of its coronavirus vaccine as nations across the world doubled down o...

Jubilant Therapeutics, The Wistar Institute join hands for COVID-19 research

ruchika17 Jan 2021 4:45 AM GMT

Bedminster: Jubilant Therapeutics Inc. has recently announced a collaboration with The Wistar Institute to evaluate the ability of Peptidyl ...

Sanofi unveils API company EUROAPI, appoints Karl Rotthier as future CEO

ruchika17 Jan 2021 3:30 AM GMT

Paris: Sanofi chooses EUROAPI as the name for the future leading European company dedicated to the development, production and marketing of active...

Biocon Chief Kiran Mazumdar Shaw, 2 others join USIBC Board as vice chairs

ruchika16 Jan 2021 7:46 AM GMT

Washington: Three top corporate leaders, including Milind Pant, CEO of Amway and Kiran Mazumdar-Shaw, executive chairperson, Biocon, have joined the 20...

Strides Pharma gets USFDA nod for Emtricitabine, Tenofovir Disoproxil Fumarate Tablets to treat HIV

ruchika16 Jan 2021 7:05 AM GMT

Bengaluru: Strides Pharma Science Limited has recently announced that the company's step-down wholly owned subsidiary, Strides Pharma Global Pte. Limit...

DCGI approves Dr Reddys Phase 3 Sputnik V clinical trial in India

ruchika16 Jan 2021 7:03 AM GMT

Hyderabad: Dr. Reddy's Laboratories Ltd has recently announced that the company has received approval from the Drugs Control General of India (DCGI) t...

Powered By: Hocalwire

We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok

X